IAP Committee for Protection of Child Consumer: statement on safety of nimesulide in children.

dc.contributor.author,en_US
dc.date.accessioned2003-08-03en_US
dc.date.accessioned2009-05-27T05:43:47Z
dc.date.available2003-08-03en_US
dc.date.available2009-05-27T05:43:47Z
dc.date.issued2003-08-03en_US
dc.identifier.citation. IAP Committee for Protection of Child Consumer: statement on safety of nimesulide in children. Indian Pediatrics. 2003 Aug; 40(8): 759-660en_US
dc.identifier.urihttps://imsear.searo.who.int/handle/123456789/12785
dc.language.isoengen_US
dc.source.urihttps://indianpediatrics.neten_US
dc.subject.meshAnalgesics --adverse effectsen_US
dc.subject.meshAnalgesics, Non-Narcotic --administration & dosageen_US
dc.subject.meshAnti-Inflammatory Agents, Non-Steroidal --adverse effectsen_US
dc.subject.meshChilden_US
dc.subject.meshHumansen_US
dc.subject.meshSulfonamides --adverse effectsen_US
dc.titleIAP Committee for Protection of Child Consumer: statement on safety of nimesulide in children.en_US
dc.typeGuidelineen_US
dc.typeJournal Articleen_US
dc.typePractice Guidelineen_US
Files
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.79 KB
Format:
Plain Text
Description: